2012 Press Releases

XORTX Pharma Corp. Announces Publication of Phase II Proof of Concept Clinical Trial in Adolescent Hypertension.

November 29, 2012December 22, 2020
by aaronbb

CALGARY- Nov 29, 2012 – XORTX Pharma Corp. wishes to congratulate Dr. Beth Soletsky and Dr Daniel Fieg on the successful completion of their phase II clinical trial in adolescent hypertension entitled “Uric Acid Reduction Rectifies Prehypertension in Obese Adolescents” and publication of results in the prestigious journal Hypertension, 2012;60:1148.
› Read more

2012 Press Releases

XORTX Pharma Corp. Raises $450,000 in First Round Financing

October 15, 2012December 22, 2020
by aaronbb

CALGARY- Oct 15, 2012 – XORTX Pharma Corp. today announced the completion of a first round of financing. Dr. Allen Davidoff stated, “The company has taken a strong step forward with the completion of this first series of financing of XORTX Pharma Corp.
› Read more

2012 Press Releases

New Private Pharmaceutical Development Company Created – XORTX Pharma Corp.

August 24, 2012December 22, 2020
by aaronbb

CALGARY – August 24, 2012 – XORTX Pharma Corp. today announced the formation of a privately held Pharmaceutical Development Company built upon novel patents (intellectual property) in the fields of hypertension, insulin resistance, metabolic syndrome and diabetes prevention.

The novel patents protect the use of all uric acid lowering agents (approved and in development) for the treatment of the aforementioned disease entities.
› Read more